Please select the option that best describes you:
Topics:
Radiation Oncology • Thoracic Malignancies • Medical Oncology • Thymoma and Thymic Carcinoma
Is there evidence supporting the role of SBRT in the management of oligometastatic stage IV NSCLC?
How does this apply to patients with brain-only oligometastases?